(Q33478602)

27 July 2017

title

Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features (English)

1 reference

hemolytic-uremic syndrome

27 July 2017

main subject

1 reference

Loirat C

1

1 reference

27 July 2017

Sonsino E

2

1 reference

27 July 2017

Varga Moreno A

3

1 reference

27 July 2017

Pillion G

4

1 reference

27 July 2017

Mercier JC

5

1 reference

27 July 2017

Beaufils F

6

1 reference

27 July 2017

Mathieu H

7

1 reference

27 July 2017

publication date

1 July 1984

1 reference

Acta Paediatrica Scandinavica

27 July 2017

published in

1 reference

27 July 2017

volume

73

1 reference

27 July 2017

issue

4

1 reference

27 July 2017

page(s)

505-514

1 reference

The haemolytic uraemic syndrome in childhood: A study of the long-term prognosis

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.1984.TB09962.X

Familial deficiency of a plasma factor stimulating vascular prostacyclin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.1984.TB09962.X

Inhibition of vascular epoprostenol (prostacyclin, PGI2) production in vitro by plasma from healthy subjects and patients with severe renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.1984.TB09962.X

Endotheliotropic (hemolytic) nephroangiopathy and its various manifestation forms (thrombotic microangiopathy, primary malignant nephrosclerosis, hemolytic-uremic syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.1984.TB09962.X

Hypodipsia in geriatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.1984.TB09962.X

Aspirin and dipyridamole therapy in the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.1984.TB09962.X

10.1111/J.1651-2227.1984.TB09962.X

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference